Newly approved pancreatic cancer drug shows promise in lung cancer NBC NewsA $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs The New York TimesFDA approves daraxonrasib for metastatic pancreatic cancer following landmark clinical trial led by Dana-Farber News-MedicalNew pancreatic cancer drug carries a $39,800 monthly list price: What to know Yahoo Finance
